Peter Goadsby is a neurologist who works on understanding the anatomy, physiology and pharmacology of primary headache disorders, such as migraine and cluster headache, while maintaining an active bedside practice. His bench and experimental medicine work identified calcitonin gene-related peptide (CGRP) as a key neurotransmitter in these disorders, directly translating that knowledge to the bedside through clinical trials. CGRP pathway monoclonal antibodies and receptor antagonists are now licensed in Europe, United States and elsewhere. He has used functional neuroimaging techniques to define the neuroanatomy of headache disorders leading to insights into the networks involved. He has developed bench models of headache disorders, identified and explored new neuropeptide and classical transmitters involved, and studied, and clinically tested, neuromodulation approaches to treatment.

Peter Goadsby is Professor of Neurology at King's College London. He was elected a fellow of the Academy of Medical Sciences in 2016. In 2021, he and his colleagues were awarded the Brain Prize for their work elucidating basic mechanisms and pharmacology of migraine and cluster headache.